341 related articles for article (PubMed ID: 36266593)
1. Construction and Evaluation of Hyaluronic Acid-Coated Flurbiprofen-Layered Double Hydroxide Ocular Drug Delivery System.
Gu D; Pan H; Xu S; Chen W; Zhu R; Jiang W; Pan W
AAPS PharmSciTech; 2022 Oct; 23(8):287. PubMed ID: 36266593
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional carboxymethyl chitosan derivatives-layered double hydroxide hybrid nanocomposites for efficient drug delivery to the posterior segment of the eye.
Wang Y; Zhou L; Fang L; Cao F
Acta Biomater; 2020 Mar; 104():104-114. PubMed ID: 31931169
[TBL] [Abstract][Full Text] [Related]
3. Multifunctional properties of organic-inorganic hybrid nanocomposites based on chitosan derivatives and layered double hydroxides for ocular drug delivery.
Xu T; Zhang J; Chi H; Cao F
Acta Biomater; 2016 May; 36():152-63. PubMed ID: 26940970
[TBL] [Abstract][Full Text] [Related]
4. Novel vehicle based on cubosomes for ophthalmic delivery of flurbiprofen with low irritancy and high bioavailability.
Han S; Shen JQ; Gan Y; Geng HM; Zhang XX; Zhu CL; Gan L
Acta Pharmacol Sin; 2010 Aug; 31(8):990-8. PubMed ID: 20686524
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid-coated niosomes facilitate tacrolimus ocular delivery: Mucoadhesion, precorneal retention, aqueous humor pharmacokinetics, and transcorneal permeability.
Zeng W; Li Q; Wan T; Liu C; Pan W; Wu Z; Zhang G; Pan J; Qin M; Lin Y; Wu C; Xu Y
Colloids Surf B Biointerfaces; 2016 May; 141():28-35. PubMed ID: 26820107
[TBL] [Abstract][Full Text] [Related]
6. [Ion-sensitive nanoemulsion-in situ gel system for ophthalmic delivery of flurbiprofen axetil].
Shen JQ; Gan Y; Gan L; Zhu CL; Zhu JB
Yao Xue Xue Bao; 2010 Jan; 45(1):120-5. PubMed ID: 21351461
[TBL] [Abstract][Full Text] [Related]
7. Functional intercalated nanocomposites with chitosan-glutathione-glycylsarcosine and layered double hydroxides for topical ocular drug delivery.
Xu T; Xu X; Gu Y; Fang L; Cao F
Int J Nanomedicine; 2018; 13():917-937. PubMed ID: 29491707
[TBL] [Abstract][Full Text] [Related]
8. Ocular delivery of flurbiprofen based on Eudragit(®) E-flurbiprofen complex dispersed in aqueous solution: preparation, characterization, in vitro corneal penetration, and ocular irritation.
Quinteros DA; Tártara LI; Palma SD; Manzo RH; Allemandi DA
J Pharm Sci; 2014 Dec; 103(12):3859-3868. PubMed ID: 25294798
[TBL] [Abstract][Full Text] [Related]
9. Zn-Al-NO(3)-layered double hydroxides with intercalated diclofenac for ocular delivery.
Cao F; Wang Y; Ping Q; Liao Z
Int J Pharm; 2011 Feb; 404(1-2):250-6. PubMed ID: 21093561
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional Nanocomposites Based on Liposomes and Layered Double Hydroxides Conjugated with Glycylsarcosine for Efficient Topical Drug Delivery to the Posterior Segment of the Eye.
Gu Y; Xu C; Wang Y; Zhou X; Fang L; Cao F
Mol Pharm; 2019 Jul; 16(7):2845-2857. PubMed ID: 31244219
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo studies on ocular vitamin A palmitate cationic liposomal in situ gels.
He W; Guo X; Feng M; Mao N
Int J Pharm; 2013 Dec; 458(2):305-14. PubMed ID: 24409520
[TBL] [Abstract][Full Text] [Related]
12. Multifunctional organic-inorganic hybrid nanoparticles and nanosheets based on chitosan derivative and layered double hydroxide: cellular uptake mechanism and application for topical ocular drug delivery.
Chi H; Gu Y; Xu T; Cao F
Int J Nanomedicine; 2017; 12():1607-1620. PubMed ID: 28280329
[TBL] [Abstract][Full Text] [Related]
13. Drug-inorganic-polymer nanohybrid for transdermal delivery.
Kim MH; Park DH; Yang JH; Choy YB; Choy JH
Int J Pharm; 2013 Feb; 444(1-2):120-7. PubMed ID: 23357253
[TBL] [Abstract][Full Text] [Related]
14. Novel NSAIDs ophthalmic formulation: flurbiprofen axetil emulsion with low irritancy and improved anti-inflammation effect.
Shen J; Gan L; Zhu C; Zhang X; Dong Y; Jiang M; Zhu J; Gan Y
Int J Pharm; 2011 Jun; 412(1-2):115-22. PubMed ID: 21440613
[TBL] [Abstract][Full Text] [Related]
15. The role of hyaluronan as a drug carrier to enhance the bioavailability of extended release ophthalmic formulations. Hyaluronan-timolol ionic complexes as a model case.
Battistini FD; Tártara LI; Boiero C; Guzmán ML; Luciani-Giaccobbe LC; Palma SD; Allemandi DA; Manzo RH; Olivera ME
Eur J Pharm Sci; 2017 Jul; 105():188-194. PubMed ID: 28506871
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronic-acid-modified lipid-polymer hybrid nanoparticles as an efficient ocular delivery platform for moxifloxacin hydrochloride.
Liu D; Lian Y; Fang Q; Liu L; Zhang J; Li J
Int J Biol Macromol; 2018 Sep; 116():1026-1036. PubMed ID: 29778883
[TBL] [Abstract][Full Text] [Related]
17. Hyalugel-integrated liposomes as a novel ocular nanosized delivery system of fluconazole with promising prolonged effect.
Moustafa MA; Elnaggar YSR; El-Refaie WM; Abdallah OY
Int J Pharm; 2017 Dec; 534(1-2):14-24. PubMed ID: 28987453
[TBL] [Abstract][Full Text] [Related]
18. Development and Characterization of Thermosensitive and Bioadhesive Ophthalmic Formulations Containing Flurbiprofen Solid Dispersions.
Adısanoğlu P; Özgüney I
Gels; 2024 Apr; 10(4):. PubMed ID: 38667685
[TBL] [Abstract][Full Text] [Related]
19. Transport mechanism of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan decorated coumarin-6 loaded nanostructured lipid carriers across the rabbit ocular.
Li J; Tan G; Cheng B; Liu D; Pan W
Eur J Pharm Biopharm; 2017 Nov; 120():89-97. PubMed ID: 28867370
[TBL] [Abstract][Full Text] [Related]
20. Formulation and evaluation of thermosensitive flurbiprofen
Maddiboyina B; Jhawat V; Desu PK; Gandhi S; Nakkala RK; Singh S
J Biomater Sci Polym Ed; 2021 Aug; 32(12):1584-1597. PubMed ID: 33977874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
